Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06555939
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-13
Brief Title:
Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Adolescents and young adults with sickle cell disease SCD face challenges managing their illness and maintaining their well-being This study proposes to test the feasibility and acceptability of a resilience-promoting intervention through a Collaborative Care Model The primary goal is to determine with the resilience intervention PRISM is feasible and acceptable for adolescents and young adults with SCD Exploratory outcomes include whether this intervention improves depression anxiety and pain interference
Detailed Description:
Adolescents and Young Adults AYAs with blood disorders are at risk for poor physical psychological and social outcomes Sickle Cell Disease SCD is a life-limiting condition defined as a group of inherited red blood cell disorders disproportionally affecting non-Hispanic Black African American and HispanicLatino groups AYAs with SCD experience racial bias disease-related stigma and under-treated symptoms all of which translate to additional challenges managing their illness and maintaining their well-being This study proposes to address the gaps of mental health support for youth with SCD through delivery of a resilience-promoting intervention PRISM using a Collaborative Care Model CoCM The primary objective of this study is to test the feasibility and acceptability of a collaborative care model to sustainably deliver the PRISM intervention for AYAs with SCD Leveraging successful strategies implemented for patients with cancer we will pilot-test this approach with N25 AYAs in the Dana-Farber Cancer InstituteBoston Childrens hospital DFCIBCH SCD clinic The primary outcome of interest is feasibility defined as 50 enrollment Secondary outcomes include patient reported outcomes of feasibility acceptability and satisfaction Exploratory outcomes include assessment of depression anxiety and pain interference We hypothesize this will be feasible and acceptable in this patient population
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None